Business Development & Partnership
Home > Business Development & Partnership
Hanmi Pharm. is dedicated to develop and provide innovative, valuable drugs to its customers. In order to pursue this goal, Hanmi is highly interested in collaborative opportunities including product in and out-licensing, co-research, co-development, co-promotion, and co-marketing with research institutes, pharmaceutical companies, and biotech companies domestically and internationally.
API
About Hanmi Pharm
Hanmi has shown remarkable growth since its foundation in 1973 and now become the most spotlighted company among Korean pharmaceutical companies. Hanmi has been successfully developed and marketed New Combination drug and a series of IMDs with its own patented process Hanmi has succeeded in developing LAPSCOVERY technology, which is enhancing the half-life time for bio-products.Paltan Plant
- Finished formulation plant for oral products (tablet, capsule, oral suspension)
- Approved by German Authority
Pyeongtaek Plant
- Cephalosporin dedicated finished formulation plant
- Compliance with the GMP Standards required by EU & US
- Contract Manufacturing Service with big Capacity (70million vial / year)
Major Products
CTD Dossier available- Cephalosporin dedicated finished formulation plant
- Compliance with the GMP Standards required by EU & US
- Contract Manufacturing Service with big Capacity (70million vial / year)
